Your browser doesn't support javascript.
loading
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.
Koeberle, Dieter; Saletti, Piercarlo; Borner, Markus; Gerber, Daniela; Dietrich, Daniel; Caspar, Clemens B; Mingrone, Walter; Beretta, Kurt; Strasser, Florian; Ruhstaller, Thomas; Mora, Oreste; Herrmann, Richard.
Affiliation
  • Koeberle D; Department of Internal Medicine, Division Oncology/Hematology, Kantonsspital St Gallen, CH-9007 St Gallen, Switzerland. dieter.koeberle@kssg.ch
J Clin Oncol ; 26(22): 3702-8, 2008 Aug 01.
Article in En | MEDLINE | ID: mdl-18669455
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Quality of Life / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2008 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Quality of Life / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2008 Type: Article Affiliation country: Switzerland